Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis

Hyperprogressive disease (HPD) is a recently acknowledged pattern of rapid tumor progression after the initiation of immune checkpoint inhibitors. HPD has been observed across various types of tumors and has been associated with poor survival. We performed a meta-analysis to identify baseline (i.e.,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jong Yeob, Lee, Keum Hwa, Kang, Jeonghyun, Borcoman, Edith, Saada-Bouzid, Esma, Kronbichler, Andreas, Hong, Sung Hwi, de Rezende, Leandro Fórnias Machado, Ogino, Shuji, Keum, Nana, Song, Mingyang, Luchini, Claudio, van der Vliet, Hans J., Shin, Jae Il, Gamerith, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896059/
https://www.ncbi.nlm.nih.gov/pubmed/31683809
http://dx.doi.org/10.3390/cancers11111699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896059/
https://www.ncbi.nlm.nih.gov/pubmed/31683809
http://dx.doi.org/10.3390/cancers11111699

Ejemplares similares